TGF-β1-Induced Epithelial–Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells

Frontiers in Oncology

Volumn 5, Issue , 2015, Pages

  Johansson, Joel ^a   Tabor, Vedrana ^a   Wikell, Anna ^a   Jalkanen, Sirpa ^b   Fuxe, Jonas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

breast cancer; epithelial mesenchymal transition; gene expression profiling; immune cells; macrophages; monocytes; properties

Indexed keywords

EID: 85105282154     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00003     Document Type: Article

References (67)

1. Chiang AC Massague J. Molecular basis of metastasis. N Engl J Med (2008) 359(26):2814–23.10.1056/NEJMra0805239
2. Chaffer CL Weinberg RA. A perspective on cancer cell metastasis. Science (2011) 331(6024):1559–64.10.1126/science.1203543
3. Jahroudi N Greenberger JS. The role of endothelial cells in tumor invasion and metastasis. J Neurooncol (1995) 23(2):99–108.10.1007/BF010534157543941
4. Kang Y Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell (2013) 23(5):573–81.10.1016/j.ccr.2013.04.01723680145
5. Kalluri R Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 119(6):1420–8.10.1172/JCI3910419487818
6. Mani SA Guo W Liao MJ Eaton EN Ayyanan A Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 133(4):704–15.10.1016/j.cell.2008.03.02718485877
7. Thiery JP Acloque H Huang RY Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell (2009) 139(5):871–90.10.1016/j.cell.2009.11.00719945376
8. Nieto MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science (2013) 342(6159):1234850.10.1126/science.123485024202173
9. Bednarz-Knoll N Alix-Panabieres C Pantel K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev (2012) 31(3–4):673–87.10.1007/s10555-012-9370-z22733306
10. Yu M Bardia A Wittner BS Stott SL Smas ME Ting DT et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 339(6119):580–4.10.1126/science.122852223372014
11. Fuxe J Karlsson MC. TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol (2012) 22(5–6):455–61.10.1016/j.semcancer.2012.05.00422627188
12. Oft M Peli J Rudaz C Schwarz H Beug H Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev (1996) 10(19):2462–77.10.1101/gad.10.19.24628843198
13. Rakonjac M Fischer L Provost P Werz O Steinhilber D Samuelsson B et al. Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci U S A (2006) 103(35):13150–5.10.1073/pnas.060515010316924104
14. Andersson AM Pettersson RF. Targeting of a short peptide derived from the cytoplasmic tail of the G1 membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex. J Virol (1998) 72(12):9585–96.9811692
15. Neve RM Chin K Fridlyand J Yeh J Baehner FL Fevr T et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 10(6):515–27.10.1016/j.ccr.2006.10.00817157791
16. Ismail-Khan R Bui MM. A review of triple-negative breast cancer. Cancer Control (2010) 17(3):173–6.20664514
17. Zavadil J Bitzer M Liang D Yang YC Massimi A Kneitz S et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A (2001) 98(12):6686–91.10.1073/pnas.11161439811390996
18. Xie L Law BK Aakre ME Edgerton M Shyr Y Bhowmick NA et al. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res (2003) 5(6):R187–98.10.1186/bcr64014580254
19. Brown KA Aakre ME Gorska AE Price JO Eltom SE Pietenpol JA et al. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res (2004) 6(3):R215–31.10.1186/bcr76215084245
20. Gal A Sjoblom T Fedorova L Imreh S Beug H Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene (2008) 27(9):1218–30.10.1038/sj.onc.121074117724470
21. Johansson J Berg T Kurzejamska E Pang MF Tabor V Jansson M et al. MiR-155-mediated loss of C/EBPbeta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene (2013) 32(50):5614–24.10.1038/onc.2013.32223955085
22. Takahashi K Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 126(4):663–76.10.1016/j.cell.2006.07.02416904174
23. Takahashi K Tanabe K Ohnuki M Narita M Ichisaka T Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 131(5):861–72.10.1016/j.cell.2007.11.019
24. Toft DJ Cryns VL. Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol (2011) 25(2):199–211.10.1210/me.2010-016420861225
25. Vandewalle C Comijn J De Craene B Vermassen P Bruyneel E Andersen H et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res (2005) 33(20):6566–78.10.1093/nar/gki96516314317
26. Bindels S Mestdagt M Vandewalle C Jacobs N Volders L Noel A et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene (2006) 25(36):4975–85.10.1038/sj.onc.120951116568083
27. Batlle E Sancho E Franci C Dominguez D Monfar M Baulida J et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 2(2):84–9.10.1038/3500003410655587
28. Cano A Perez-Moreno MA Rodrigo I Locascio A Blanco MJ Del Barrio MG et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol (2000) 2(2):76–83.10.1038/3501050610655586
29. Casas E Kim J Bendesky A Ohno-Machado L Wolfe CJ Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res (2011) 71(1):245–54.10.1158/0008-5472.CAN-10-233021199805
30. Hajra KM Chen DY Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res (2002) 62(6):1613–8.11912130
31. Peinado H Olmeda D Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer (2007) 7(6):415–28.10.1038/nrc213117508028
32. Vincent T Neve EP Johnson JR Kukalev A Rojo F Albanell J et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol (2009) 11(8):943–50.10.1038/ncb190519597490
33. Yang J Mani SA Donaher JL Ramaswamy S Itzykson RA Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 117(7):927–39.10.1016/j.cell.2004.06.00615210113
34. Shirakihara T Saitoh M Miyazono K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell (2007) 18(9):3533–44.10.1091/mbc.E07-03-024917615296
35. Van Kempen LC Coussens LM. MMP9 potentiates pulmonary metastasis formation. Cancer Cell (2002) 2(4):251–2.10.1016/S1535-6108(02)00157-512398887
36. Sethi N Dai X Winter CG Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell (2011) 19(2):192–205.10.1016/j.ccr.2010.12.02221295524
37. Gattelli A Nalvarte I Boulay A Roloff TC Schreiber M Carragher N et al. Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells. EMBO Mol Med (2013) 5(9):1335–50.10.1002/emmm.20130262523868506
38. Oskarsson T Acharyya S Zhang XH Vanharanta S Tavazoie SF Morris PG et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 17(7):867–74.10.1038/nm.237921706029
39. Baruzzi A Iacobucci I Soverini S Lowell CA Martinelli G Berton G. c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration. FEBS Lett (2010) 584(1):15–21.10.1016/j.febslet.2009.11.00919903482
40. Yadav V Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog (2011) 50(5):346–52.10.1002/mc.2071621480388
41. Hajjawi MO Macrae VE Huesa C Boyde A Millan JL Arnett TR et al. Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1 mice. Bone (2014) 69C:139–47.10.1016/j.bone.2014.09.01625260930
42. Lau WM Doucet M Stadel R Huang D Weber KL Kominsky SL. Enpp1: a potential facilitator of breast cancer bone metastasis. PLoS One (2013) 8(7):e66752.10.1371/journal.pone.006675223861746
43. Elias D Vever H Laenkholm AV Gjerstorff MF Yde CW Lykkesfeldt AE et al. Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene (2014).10.1038/onc.2014.13824882577
44. Umar A Kang H Timmermans AM Look MP Meijer-Van Gelder ME Den Bakker MA et al. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol Cell Proteomics (2009) 8(6):1278–94.10.1074/mcp.M800493-MCP20019329653
45. Gu H Botelho RJ Yu M Grinstein S Neel BG. Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis. J Cell Biol (2003) 161(6):1151–61.10.1083/jcb.20021215812821647
46. Ke Y Wu D Princen F Nguyen T Pang Y Lesperance J et al. Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene (2007) 26(34):4951–60.10.1038/sj.onc.121031517310989
47. Gingras MC Margolin JF. Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization. Exp Hematol (2000) 28(1):65–76.10.1016/S0301-472X(99)00126-510658678
48. Awasthi A Woolley AG Lecomte FJ Hung N Baguley BC Wilbanks SM et al. Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Front Oncol (2013) 3:225.10.3389/fonc.2013.0022524010123
49. Kim TR Yoon JH Kim YC Yook YH Kim IG Kim YS et al. LPS-induced CD53 expression: a protection mechanism against oxidative and radiation stress. Mol Cells (2004) 17(1):125–31.15055538
50. Yu M Tsai M Tam SY Jones C Zehnder J Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest (2006) 116(6):1633–41.10.1172/JCI2570216710480
51. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med (2010) 363(2):166–76.10.1056/NEJMra0905980
52. Nalls MA Plagnol V Hernandez DG Sharma M Sheerin UM Saad M et al. Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet (2011) 377(9766):641–9.10.1016/S0140-6736(10)62345-821292315
53. Thevenet J Pescini Gobert R Hooft Van Huijsduijnen R Wiessner C Sagot YJ. Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS One (2011) 6(6):e21519.10.1371/journal.pone.002151921738687
54. Kronlage M Song J Sorokin L Isfort K Schwerdtle T Leipziger J et al. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal (2010) 3(132):ra55.10.1126/scisignal.200058820664064
55. Haynes SE Hollopeter G Yang G Kurpius D Dailey ME Gan WB et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci (2006) 9(12):1512–9.10.1038/nn180517115040
56. Sica GL Zhu G Tamada K Liu D Ni J Chen L. RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-kappaB. Blood (2001) 97(9):2702–7.10.1182/blood.V97.9.270211313261
57. Zschiedrich I Hardeland U Krones-Herzig A Berriel Diaz M Vegiopoulos A Muggenburg J et al. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood (2008) 112(2):264–76.10.1182/blood-2007-11-12169918469200
58. Harada Y Tanaka Y Terasawa M Pieczyk M Habiro K Katakai T et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood (2012) 119(19):4451–61.10.1182/blood-2012-01-40709822461490
59. Hata M Takahara S Tsuzaki H Ishii Y Nakata K Akagawa KS et al. Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2). Immunol Lett (2009) 126(1–2):29–36.10.1016/j.imlet.2009.07.00819643136
60. Chou HC Anton IM Holt MR Curcio C Lanzardo S Worth A et al. WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cells. Curr Biol (2006) 16(23):2337–44.10.1016/j.cub.2006.10.03717141616
61. Devaraj S Davis B Simon SI Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol (2006) 291(3):H1170–6.10.1152/ajpheart.00150.200616603696
62. Palani S Maksimow M Miiluniemi M Auvinen K Jalkanen S Salmi M. Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages. Eur J Immunol (2011) 41(7):2052–63.10.1002/eji.20104137621480214
63. Liu L Cara DC Kaur J Raharjo E Mullaly SC Jongstra-Bilen J et al. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J Exp Med (2005) 201(3):409–18.10.1084/jem.2004083015684321
64. Sutherland JM Mclaughlin EA Hime GR Siddall NA. The Musashi family of RNA binding proteins: master regulators of multiple stem cell populations. Adv Exp Med Biol (2013) 786:233–45.10.1007/978-94-007-6621-1_1323696360
65. Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res (2007) 13(14):4042–5.10.1158/1078-0432.CCR-06-231617634527
66. Ishida D Kometani K Yang H Kakugawa K Masuda K Iwai K et al. Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice. Cancer Cell (2003) 4(1):55–65.10.1016/S1535-6108(03)00163-612892713
67. Kim ST Sohn I Do IG Jang J Kim SH Jung IH et al. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer. Cancer Genomics Proteomics (2014) 11(5):259–66.25331798